2 Safety Nets to Own in Case of a Pre-Endemic Market Selloff

The stock market remains vulnerable to a market correction in 2022, so investors should be ready to pick up two safety nets for capital protection.

| More on:
edit Safe pig, protect money

Image source: Getty Images

The Omicron crisis is proof that the pandemic is far from over. While cases continue to surge globally, some predict this new COVID variant is a less-virulent virus. It could also be the prelude to an endemic environment. However, a market selloff is still possible before we reach an acceptable steady state.

Investors should prepare for any eventuality and be ready with their safety nets. If you have time to rebalance your portfolio, pick up shares of Fortis (TSX:FTS)(NYSE:FTS) and Alimentation Couche-Tard (TSX:ATD). The stocks will hold steady regardless the economic environment. Even the dividend payouts should also be safe and uninterrupted.

Sustained inflation

Besides the pandemic, rising inflation could unsettle the market. Royal Bank of Canada CEO David McKay doesn’t think the recent acceleration of inflation was transitory. He said the Bank of Canada needs to take “rapid action” with multiple interest rate increases to bring inflation under control.

McKay added, “This is permanent, sustained inflation that has to be dealt with through monetary policy, and therefore, we need rapid action this spring as a series of rate increases to address it.” Some analysts say there should be at least five rate hikes, with the first on January 26, 2022.

Sam Stovall, the chief investment strategist at CFRA Research, expects the consumer price index (CPI) to peak around 7.1% in 2022 and decelerate to 3.2% year-end.

Long-term, profitable growth

Fortis is the top-of-mind choice of risk-averse investors. The $27.83 billion company oversees diverse affiliated companies, including 10 affiliated electric and gas operations. This top-tier utility stock is a defensive asset, given the regulated, low-risk, and diversified business model.

Management has increased its dividends from 48 consecutive calendar years. Now is also the best the time to own the stock. Fortis has a promise to hike dividends by approximately 6%, on average annually, through 2025. The company should have no problems delivering on its commitment to shareholders.

David Hutchens, Fortis president and CEO, said the new five-year capital plan (2022 to 2026) of $20 billion is the company’s largest to date. Hutchens added, “The new plan is highly executable with approximately 85% consisting of relatively small projects.” At $58.86 per share, the dividend offer is a respectable 3.62% dividend.

Multiple avenues for growth

RBC recently released its top 30 global stock picks for 2022. Alimentation Couche-Tard is one of seven Canadian firms that received a thumbs up from Canada’s largest bank. According to RBC analyst Irene Nattel, the $53.81 billion multinational operator of convenience stores has multiple avenues for growth.

Couche-Tard currently has 14,200 stores in 26 countries and territories. Nattel said the recent acquisition in Asia gives the company another platform for acceleration growth. In December 2021, Couche-Tard acquired the assets of Pik Quik in the state of New Mexico. According to management, the 19 high-quality, well-run sites fits perfectly with Couche-Tard’s existing network.

Alex Miller, Couch-Tard’s EVP for Operations in North America, said, “With this acquisition, we will be able to build on our strong network in the state.” The consumer-defensive stock trades at $50.67 per share and pays a modest 0.87% dividend. RBC forecast a 48% return potential to $74.99 by early 2023.

Safety nets

Overcome the uncertainties with Fortis and Couche-Tard. The safety nets offer capital protection and recurring income streams.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool owns and recommends Alimentation Couche-Tard Inc. The Motley Fool recommends FORTIS INC.

More on Dividend Stocks

Concept of multiple streams of income
Dividend Stocks

Passive Income: How Much Do You Need to Invest to Make $400 Per Month?

This fund's fixed $0.10-per-share monthly payout makes passive-income math easy.

Read more »

voice-recognition-talking-to-a-smartphone
Dividend Stocks

How to Turn Losing TSX Telecom Stock Picks Into Tax Savings

Telecom stocks could be a good tax-loss harvesting candidate for year-end.

Read more »

Business success of growth metaverse finance and investment profit graph concept or development analysis progress chart on financial market achievement strategy background with increase hand diagram
Dividend Stocks

2 Dividend Growth Stocks Look Like Standout Buys as the Market Keeps Surging

Enbridge (TSX:ENB) stock and another standout name to watch closely in the new year.

Read more »

a person watches stock market trades
Dividend Stocks

For Passive Income Investing, 3 Canadian Stocks to Buy Right Now

Don't look now, but these three Canadian dividend stocks look poised for some big upside, particularly as interest rates appear…

Read more »

Dividend Stocks

Got $7,000? Where to Invest Your TFSA Contribution in 2026

Putting $7,000 to work in your 2026 TFSA? Consider BMO, Granite REIT, and VXC for steady income, diversification, and long-term…

Read more »

Young adult concentrates on laptop screen
Dividend Stocks

A Beginner’s Guide to Building a Passive Income Portfolio

Are you a new investor looking to earn safe dividends? Here are some tips for a beginner investor who wants…

Read more »

container trucks and cargo planes are part of global logistics system
Dividend Stocks

Before the Clock Strikes Midnight on 2025 – TSX Transportation & Logistics Stocks to Buy

Three TSX stocks are buying opportunities in Canada’s dynamic and rapidly evolving transportation and logistics sector.

Read more »

some REITs give investors exposure to commercial real estate
Dividend Stocks

The Ideal Canadian Stock for Dividends and Growth

Want dividends plus steady growth? Power Corporation offers a “quiet compounder” mix of cash flow today and patient compounding from…

Read more »